Sagimet Biosciences (SGMT) IPO deck
Sagimet Biosciences is a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic pathways.
Sagimet Biosciences is a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic pathways.
%20IPO%20deck){kind=link}